# Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD

> **NCT03389698** · — · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 27 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DEVICE:** GRASP Dynamic Contrast-Enhanced (DCE) MRI
- **DEVICE:** 3T Brain Scan
- **DRUG:** Gadolinium-based Contrast Agent (GBCA) for MRI

## Key facts

- **NCT ID:** NCT03389698
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-18
- **Primary completion:** 2022-01-28
- **Final completion:** 2023-07-11
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03389698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03389698, "Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03389698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*